
Restor3d Buys Conformis in Medical 3D Printing Deal
3D-printed orthopedics company restor3d Inc. has entered into a definitive agreement to acquire all outstanding common stock shares of Conformis, which has “image-to-implant” technology to fabricate patient-specific knee implants in its product portfolio. The $2.27 per share in cash offered by restor3D represents an approximate 96% premium to the closing price of Conformis stock on June 22, 2023. The deal is expected to close by the end of the third quarter…